Ionis Pharmaceuticals has announced their ASO will be headed to clinical trial in the 2nd half of 2020! We have been watching the dramatic & beneficial affect of these therapies for other disorders. Now it is our turn.
#fastSUMMIT2019#fastGALA2019#cureangelmannow